Azithromycin Price Trend and Forecast

Azithromycin Regional Price Overview

Get the latest insights on price movement and trend analysis of Azithromycin in different regions across the world (Asia, Europe, North America, Latin America, and the Middle East & Africa).


Azithromycin Price Trend for the Q1 of 2024

Product Category Region Price Time Period
Azithromycin Chemicals Europe USD 1000/MT/MT March 2024

Stay updated with the latest Azithromycin prices, historical data, and tailored regional analysis


In India, azithromycin is one of the medicines listed on the National List of Essential Medicines (NLEM) since it is considered essential for addressing infectious diseases and is commonly prescribed by healthcare providers in India for various bacterial infections. The prices for these medicines are greatly regulated by the NPPA (National Pharmaceutical Pricing Authority) of India. Thus, the prices do not show much fluctuations despite the variations in upstream manufacturing and processing costs. The government wants these medicines to be readily available at cheaper prices for the low-earning population as well. So, the azithromycin prices remained almost stagnant during the given span of Q1’24.

Azithromycin Price Chart

Azithromycin Price Trends and Forecast

Please Login or Subscribe to Access the Azithromycin Price Chart Data

NPPA has, however, announced a marginal increase of about 0.00551% to MRPs of NLEM drugs, including azithromycin, from April 2024. This minimal rise in prices, however, is not sitting right with the manufacturing firms as they are struggling with grappling increases in raw material costs, processing charges, and shipping rates. The revenue margins have been contracting consistently.

As various small and medium players in the drug market struggle to comply with the new, more strict rules of the health ministry regulations, many of them are expected to undergo closures. This will likely create a supply crunch in the medicine market. Troubled with this highly regulated essential medicine sector many big companies are shifting focus from essential medicines. The government is also reviewing the DPCO (Drug Price Control Order) to aid this market situation.

North America

In the USA, pharmaceutical companies have increased prices for over 700 medications at the start of the year, with an average increase of about 4.5%. Thus the azithromycin prices also experienced marginal rise in average prices. These increases are part of a trend where most brand prescription drug list price hikes occur in January or July each year.

The USA is considered one of the most expensive drug markets in the world. However, despite sticker price increases, net prices, which consider rebates and discounts, have been decreasing for about six years. The American Rescue Plan Act, passed in 2021, has led to record decreases in list prices for drugs like insulin and inhalers. These price hikes coincide with ongoing efforts in Washington, D.C., to address high drug costs, including medicare negotiation powers and limiting price increases to inflation rates.

Analyst Insight

According to Procurement Resource, the Azithromycin prices are likely to exude borderline stagnancy in the coming months as well. Not much change is anticipated in the drug prices moving forward.

Azithromycin Price Trend for the October - December of 2023


In order to counter the recent price hikes in the pharmaceutical sector and to curb the rising medical inflation in the country, the Indian government/ agencies are actively interviewing to increase affordability. Currently, the Supreme Court is addressing objections raised by the All India Drug Action Network on the drug pricing formula, citing concerns about super-profits, exclusion of critical medicines, and insufficient consultation.

Recently, the Indian National Pharmaceutical Pricing Authority (NPPA) has brought 33 fixed-dose combination drugs under regulation; manufacturers failing to comply with the price cap must reimburse overcharged amounts with interest. This step is all set to control the drug pricing, including Azithromycin prices, in the coming months.

North America

The pharmaceutical industry, including companies like Merck, Bristol-Myers Squibb, and Johnson & Johnson, is countering the US administration's drug price negotiation. The Inflation Reduction Act aims to lower drug costs and requires rebates if prices rise faster than inflation. Multiple lawsuits challenging the constitutionality of the program are in progress, with the industry arguing against unprecedented restrictions on drug prices.

Recently, companies, including Pfizer, Sanofi, and Takeda, plan to raise prices on over 500 drugs, including Azithromycin, starting January 2024 in order to counter the US Administration's publication of discounted prices for ten high-cost drugs. Further, the concerns about supply chain disruptions and rising costs of raw materials and manufacturing are also influencing the global pharmaceutical industry.

Analyst Insight

According to Procurement Resource, the Azithromycin price trend are likely to remain fluctuating in the coming quarter, given the current economic scenario and the pricing fundamentals. The ongoing disagreement between the US administration and the global pharmaceutical giants will greatly affect the global markets.

Azithromycin Price Trend for the July - September of 2023


Azithromycin is a potent antibiotic drug used for various purposes and symptoms in modern pharmaceuticals. Because of its widespread use, the demands from the consuming sectors are usually stable. During the third quarter, in line with the price forecasts, the Azithromycin prices inclined throughout.

The production costs were high because of inflation, and the disease season in India further escalated the azithromycin demand in the market. With these situations, the azithromycin prices rose consistently on the price graph. Overall, the Azithromycin market outlook was observed to be very positive throughout the said period.


The azithromycin situation in Europe was not much different from the Azithromycin market in Asia. Along with the consistent demands from the end user and consumer sectors, the growing transportation charges amidst weather disruptions also influenced the azithromycin price trend during the said period. Overall, positive market trend were observed.

North America

Following the other key global markets, the azithromycin prices in America also inclined throughout the said period. As the Chinese supplies were trying to cater to the domestic demand, the American imports struggled too, and thus, amidst a positive supply and demand dynamic, the prices grew consistently during the said period.

Analyst Insight

According to Procurement Resource, the Azithromycin price trend are likely to continue to rise in the coming months, given the stable market fundamentals.

Azithromycin Price Trend for the First Half of 2023


The azithromycin sector witnessed positive price growth in the first and second quarters of 2023. The rise was gradual in the first quarter but was steep in the second quarter. This upward trajectory in the prices of Azithromycin was supported by the decline in inventories and rising demand from the end-user sector.

Also, after a long period of stagnancy in China due to the lunar holiday season, the market regained its production potential. In the second quarter, the downstream industries raised their number of orders, and with rising inflation rates and soaring energy production prices, the trend of Azithromycin inclined significantly.


The market for Azithromycin was stagnant in the first quarter of 2023 as the purchasing potential of the pharmaceutical sector and the supply of the product in the region balanced each other. However, in the second quarter, the price trend inclined significantly. In Q2, the demand from the domestic and international players rose remarkably with the positive movement of the regional market. In addition, the ongoing Russia-Ukraine war caused the cost of energy production to rise, and as a result, the price trend of Azithromycin moved swiftly towards a positive trajectory.

North America

The price trend seen in the European region was also followed in North America. In the first quarter, the price trend increased gradually, supported by the consistent demand from the pharmaceutical sector and ease in trading activities.

In the second quarter, the rise in imports from China and increasing production activities of the downstream sector influenced the azithromycin market. In addition to this, the inflation in the region declined, and the energy cost surged, which further supported the azithromycin market.
Analyst Insight

According to Procurement Resource, the price of Azithromycin is expected to witness an inclining trajectory as the demand from the downstream industries and the cost of energy production are estimated to rise.

Procurement Resource provides latest prices of Azithromycin. Each price database is tied to a user-friendly graphing tool dating back to 2014, which provides a range of functionalities: configuration of price series over user defined time period; comparison of product movements across countries; customisation of price currencies and unit; extraction of price data as excel files to be used offline.

Platform Sample

Please Login or Subscribe to explore our dashboard.

About Azithromycin

A member of the macrolide class of antibiotics, azithromycin has a broad spectrum of activity. It is frequently used to treat a number of bacterial infections, including skin infections, sexually transmitted diseases, and infections of the respiratory tract. By blocking the creation of bacterial proteins, azithromycin stops the growth and spread of bacteria.

Its lengthy half-life, which enables once-daily dosing and provides patients with convenience, is one of its important characteristics. Additionally, it has significant tissue penetration, making it possible to treat infections in different bodily regions effectively. Its favorable side effects and suitability for those with penicillin allergies make azithromycin a desirable and frequently given antibiotic.

Azithromycin Product Details

Report Features Details
Product Name Azithromycin
Chemical Formula C38H72N2O12
CAS Number Veterinary medicine, Disease prevention in agricultural crops
Molecular Weight 83905015
HS Code 29419090
Supplier Database Pfizer, Akron, Teva, Mylan, Zydus Pharmaceuticals, Sandoz, Aurbindo Pharma, CSPC Ouyi Pharmaceutical, Hainan Poly Pharm
Region/Countries Covered Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Iran, Thailand, South Korea, Iraq, Saudi Arabia, Malaysia, Nepal, Taiwan, Sri Lanka, UAE, Israel, Hongkong, Singapore, Oman, Kuwait, Qatar, Australia, and New Zealand

Europe: Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece

North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru

Africa: South Africa, Nigeria, Egypt, Algeria, Morocco
Currency US$ (Data can also be provided in local currency)
Supplier Database Availability Yes
Customization Scope The report can be customized as per the requirements of  the customer
Post-Sale Analyst Support 360-degree analyst support after report delivery

Note: Our supplier search experts can assist your procurement teams in compiling and validating a list of suppliers indicating they have products, services, and capabilities that meet your company's needs.

Azithromycin Production Processes

The production of intermediate molecules is the first step in the synthesis of azithromycin. Amination, acylation, esterification, cyclization, purification, isolation, and quality control are the next steps. The intermediate component is processed to attach molecules with amine and acyl functional groups, which are then subjected to cyclization to combine all the compounds into one finished product, in this case azithromycin.

In a very certain temperature and environment, the process is watched over and managed. Following cyclization, the chemical compound is refined and isolated to guarantee complete purity and retain the chemical compound's quality.


The displayed pricing data is derived through weighted average purchase price, including contract and spot transactions at the specified locations unless otherwise stated. The information provided comes from the compilation and processing of commercial data officially reported for each nation (i.e. government agencies, external trade bodies, and industry publications).

Assistance from Experts

Procurement Resource is a one-stop solution for businesses aiming at the best industry insights and market evaluation in the arena of procurement. Our team of market leaders covers all the facets of procurement strategies with its holistic industry reports, extensive production cost and pre-feasibility insights, and price trends dynamics impacting the cost trajectories of the plethora of products encompassing various industries. With the best analysis of the market trends and comprehensive consulting in light of the best strategic footstep, Procurement Resource got all that it takes.

Client's Satisfaction

Procurement Resource has made a mark for itself in terms of its rigorous assistance to its clientele. Our experienced panel of experts leave no stone unturned in ensuring the expertise at every step of our clients' strategic procurement journey. Our prompt assistance, prudential analysis, and pragmatic tactics considering the best procurement move for industries are all that sets us apart. We at Procurement Resource value our clients, which our clients vouch for.

Assured Quality

Expertise, judiciousness, and expedience are the crucial aspects of our modus operandi at Procurement Resource. Quality is non-negotiable, and we don't compromise on that. Our best-in-class solutions, elaborative consulting substantiated by exhaustive evaluation, and fool-proof reports have led us to come this far, making us the ‘numero uno' in the domain of procurement. Be it exclusive qualitative research or assiduous quantitative research methodologies, our high quality of work is what our clients swear by.

Table Of Contents

Our Clients


Get in Touch With Us


Phone:+1 307 363 1045


Phone: +91 1203185500


Phone: +44 7537 132103



Get latest News About Procurement Resource
Subscribe for news

This site uses cookies (including third-party cookies) to record user’s preferences. See our Privacy PolicyFor more.